Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of Affective Disorders|January 20, 2010
Behavioural addictions in bipolar disorder patients: role of impulsivity and personality dimensionsMarco Di Nicola, Daniela Tedeschi, Marianna Mazza, et al.Addictive Behaviors|March 18, 2014
Is Internet addiction a psychopathological condition distinct from pathological gambling?Federico Tonioni, Marianna Mazza, Gianna Autullo, et al.Journal of Affective Disorders|October 11, 2008
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-upMarianna Mazza, Laura Mandelli, Marco Di Nicola, et al.Psychopathology|March 9, 2012
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcomeLaura Mandelli, Marianna Mazza, Marco Di Nicola, et al.Diagnostics (Basel, Switzerland)|January 8, 2025
Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An UpdateGiuseppe Stefano Netti, Dario Troise, Michele Rossini, et al.International Journal of Psychiatry in Clinical Practice|February 3, 2012
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-upMarianna Mazza, Laura Mandelli, Leonardo Zaninotto, et al.Nordic Journal of Psychiatry|July 7, 2011
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed stateMarianna Mazza, Laura Mandelli, Leonardo Zaninotto, et al.Behavioral Medicine (Washington, D.C.)|February 13, 2013
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patientsDésirée Harnic, Maurizio Pompili, Marianna Mazza, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 17, 2022
mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipientsGiuseppe S Netti, Barbara Infante, Dario Troise, et al.Biomedicines|June 27, 2024
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective StudyGiuseppe Stefano Netti, Piera Soccio, Valeria Catalano, et al.Pageof 3